Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 316

1.
3.
4.

Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.

Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira J, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H.

Mod Pathol. 2004 Aug;17(8):962-72.

5.

Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix.

Hayashi I, Tsuda H, Shimoda T, Maeshima A, Kasamatsu T, Yamada T, Tsunematsu R.

Virchows Arch. 2003 Dec;443(6):752-60. Epub 2003 Oct 11.

PMID:
14556072
6.

Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.

Takatsu A, Shiozawa T, Miyamoto T, Kurosawa K, Kashima H, Yamada T, Kaku T, Mikami Y, Kiyokawa T, Tsuda H, Ishii K, Togashi K, Koyama T, Fujinaga Y, Kadoya M, Hashi A, Susumu N, Konishi I.

Int J Gynecol Cancer. 2011 Oct;21(7):1287-96. doi: 10.1097/IGC.0b013e31821f746c.

PMID:
21685796
7.

Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.

Nishio S, Tsuda H, Fujiyoshi N, Ota S, Ushijima K, Sasajima Y, Kasamatsu T, Kamura T, Matsubara O.

Pathol Res Pract. 2009;205(5):331-7. doi: 10.1016/j.prp.2008.12.002. Epub 2009 Jan 23.

PMID:
19167836
8.

Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study.

Kawauchi S, Kusuda T, Liu XP, Suehiro Y, Kaku T, Mikami Y, Takeshita M, Nakao M, Chochi Y, Sasaki K.

Am J Surg Pathol. 2008 Dec;32(12):1807-15. doi: 10.1097/PAS.0b013e3181883722.

PMID:
18779726
9.

Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection.

Nara M, Hashi A, Murata S, Kondo T, Yuminamochi T, Nakazawa K, Katoh R, Hoshi K.

Gynecol Oncol. 2007 Aug;106(2):289-98. Epub 2007 May 30.

PMID:
17540439
10.

Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).

Takatsu A, Miyamoto T, Fuseya C, Suzuki A, Kashima H, Horiuchi A, Ishii K, Shiozawa T.

Virchows Arch. 2013 Jun;462(6):645-51. doi: 10.1007/s00428-013-1417-1. Epub 2013 May 4.

PMID:
23645358
11.

Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix.

Tsuda H, Mikami Y, Kaku T, Akiyama F, Hasegawa T, Okada S, Hayashi I, Kasamatsu T.

Pathol Int. 2003 Jul;53(7):440-9.

PMID:
12828609
12.

PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.

Rabban JT, McAlhany S, Lerwill MF, Grenert JP, Zaloudek CJ.

Am J Surg Pathol. 2010 Feb;34(2):137-46. doi: 10.1097/PAS.0b013e3181c89c98.

PMID:
20061933
13.

Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.

Tsuji T, Togami S, Nomoto M, Higashi M, Fukukura Y, Kamio M, Yonezawa S, Douchi T.

Histopathology. 2011 Jul;59(1):55-62. doi: 10.1111/j.1365-2559.2011.03886.x.

PMID:
21771026
14.

Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma.

He Y, Li L, Jiang W, Wang DQ, Xu L, Huang Q, Zhang Y, Yang KX.

Pathol Res Pract. 2011 May 15;207(5):295-9. doi: 10.1016/j.prp.2011.02.011. Epub 2011 Apr 16.

PMID:
21497449
16.

Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia.

Xu JY, Hashi A, Kondo T, Yuminamochi T, Nara M, Hashi K, Murata S, Katoh R, Hoshi K.

Int J Gynecol Pathol. 2005 Jul;24(3):296-302.

PMID:
15968208
17.

Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.

Mikami Y, Hata S, Melamed J, Fujiwara K, Manabe T.

Histopathology. 2001 Oct;39(4):364-72.

PMID:
11683936
18.

Mitotic activity and apoptosis in endocervical glandular lesions.

Moritani S, Ioffe OB, Sagae S, Dahmoush L, Silverberg SG, Hattori T.

Int J Gynecol Pathol. 2002 Apr;21(2):125-33.

PMID:
11917221
19.

Case of minimal deviation adenocarcinoma: possible clinical link to lobular endocervical glandular hyperplasia as its origin.

Sugihara T, Nakagawa S, Sasajima Y, Matsumoto Y, Takeshita S, Ayabe T.

J Obstet Gynaecol Res. 2015 Mar;41(3):483-7. doi: 10.1111/jog.12538. Epub 2014 Sep 26.

PMID:
25257165
20.

[Adenoma malignum and lobular endocervical glandular hyperplasia (LEGH)].

Shiozawa T.

Nihon Rinsho. 2012 Jun;70 Suppl 4:114-21. Japanese. No abstract available.

PMID:
23156228

Supplemental Content

Support Center